Production of IL-17 by human Th17 cell derived from patients with multiple sclerosis, or by γδ T cells from patients with inflammatory bowel disease (IBD) can be strongly suppressed by supplementation of SCFAs such as propionate (see below for a more detailed overview) [36,37]. The gene discussed is IL17A; the disease is inflammatory bowel disease.